Sleep DisturbanceAkuSleepNCT04290650
Sleep Disturbances in Patients With Psychotic Symptoms (AkuSleep)
A study testing Modified CBT for insomnia and Treatment as usual in people with Sleep Disturbance and Psychotic Disorders, run by Oslo University Hospital at 1 site in Norway.
Trial summary
Sleep disturbance is recognized as a major problem for patients with psychosis and is seen in nearly all patients admitted in acute crisis to a psychiatric hospital. Cognitive behavioral treatment is recommended as first-line treatment for insomnia in national and international guidelines. Read more about this study
- Who is it for?
- Ages 18 to 95 years
- Conditions the study is for
- Sleep Disturbance, Psychotic Disorders
- What is being tested?
- Modified CBT for insomnia and Treatment as usual
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 75 participants
- Where
- 1 siteNorway
- Study dates
- 1 Sep 2020to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 95 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients admitted to th he Acute Psychiatric Department at Oslo University who are able to consent
Who cannot join
- Patients not able to consent
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The AkuSleep Study- Treating Sleep Disturbances in Patients With Psychotic Symptoms in an Acute Ward Setting Using Cognitive Behavioral Treatment Techniques
Sleep disturbance is recognized as a major problem for patients with psychosis and is seen in nearly all patients admitted in acute crisis to a psychiatric hospital.
Cognitive behavioral treatment is recommended as first-line treatment for insomnia in national and international guidelines. This study explores effect of adapting the milieu therapy to comply with the principles of CBT for insomnia. Our aim is to rethink our day to day psychological interventions and our around the clock milieu therapy for patients with acute and severe mental illness in light of established knowledge on how sleep is obtained and maintained.
Read the detailed description
Sleep disturbances are highly prevalent among patients admitted to any hospital ward, but in particular in psychiatric patients where insomnia and poor sleep quality is a major clinical challenge.
Approximately 950 patients are admitted to The Acute Psychiatric Department at Oslo University each year. The majority of the patients (approximately 450) admitted for more than 48 hours have a severe psychotic disorder and after being evaluated by a psychiatrist upon admittance, they are allocated to one of three similar wards specialized in the treatment of psychosis. A majority of the patients experience sleep difficulties both in terms of insomnia and problems regulating circadian rhythm. Psychiatric wards in general offer several challenges to sleep, including limited access to natural daylight, noisy environment and frequent observations by staff during night for risk management purposes. A part from offering medication which the patient often declines, staff members possess little means as to how to cope with noise and agitation at night time due to frustrated patients unable to find rest.
In September 2019 our department started organizing the treatment for psychotic patients in three similar wards ("psychosis wards") and patients were allocated to a ward according to their date of birth. Nurses are stationed permanently at each ward, while psychiatrist and psychologists make up a "specialist pool" serving all three psychosis wards. One of the main intentions for organizing the department and treatment this way is to ensure that all patients with psychotic disorders receive the same treatment according to recommended guidelines.
The aim of our study is to rethink our day to day psychological interventions and our around the clock milieu therapy for our patients with acute and severe mental illness in light of established knowledge on how sleep is obtained and maintained. After making physical adjustments to the ward environment and training allocated nurses in modified CBT techniques, the AkuSleep intervention will start up in March 2020 and will be carried out for up to six months. All patients admitted one of the psychosis wards will be offered the same customized treatment focusing on sleep, whereas all the patients admitted to the other two psychosis wards will receive treatment as usual (TAU). Upon discharge, all patients admitted to the Department of Acute Psychiatry who are able to give informed consent are asked to give a broad consent allowing us to systemize clinical information from hospital records for research purposes.
The AkuSleep protocol is as follows:
- Identify the nature of the patient's sleeping problems and discuss suitable adjustments with the patient. These adjustments would typically be to focus on circadian rhythm, such as getting up in the morning at set times, avoiding coffee and strenuous physical and emotional activities at night time, avoiding staying in bed when sleep is not achieved and optimizing light/dark exposure. An acute ward setting such as ours is often noisy and many of our patients have restrictions due to security reasons which limit the access to natural day light. Simple physical measures will be implemented such as providing ear plugs, providing night lamps so that staff don't need to turn on lights on rounds, secure speakers so that the patients may listen to soothing music, easy blinds to secure a dark room at night and bean bags (or chairs) in every room so that the patient can get out of bed when sleep is not achieved. The use of daylight lamps will be offered for patients who due to security reasons or otherwise are denied access to natural daylight.
- Trained nurses will perform a short 20 minute daily session with the patient addressing tailored measures in accordance with the modified CBT for insomnia. Assessment of the individual patient's specific sleeping problems is vital for an effective treatment. Sleeping problems/disorders typically falls in to three categories; disturbance in the sleep/wake homeostasis, disturbance in the circadian rhythm and/or hyperarousal. Detecting the nature of the sleeping disorder, maintenance factors and individual goals for treatment will give way to a sleep-focused case formulation that will guide further strategies. The use of sleep and activity monitoring devices will be offered for those who find it useful. Information from monitoring devices will be used for the purpose psychoeducation and as basis for the sleep diary and relevant information will be registered in the clinical records. Data from monitoring devices will not be stored electronically. Intentions available for the patient and therapist are gathered from CBT for insomnia and will involve establishing a firm associations between bed and sleep through the use of stimulus control and the setting of a consistent sleep window (time spent in bed); activity scheduling to promote good wake-up routines and help build up necessary sleep pressure; targeting hyperarousal through systematic wind-down strategies, relaxation training etc. Psychotic symptoms such as hallucinations and delusions are also prone to give disturbance in the ability to either getting to or staying asleep. These symptoms will be incorporated in the specific formulation for treatment and management of the symptoms will be a part of later strategies promoting good sleep hygiene. The implemented measures will be monitored and evaluated throughout the whole period so that adjustments can be made on a daily basis and in accordance with the formulation and the patient's goals. The details of the individual treatment progress will be written in a patient owned workbook, giving all trained staff members an opportunity to step in at any time to continue the therapeutic work. The workbook will be given to the patient at their time of discharge with instructions of further use.
The teaching of the nursing staff will cover topics to enable them to give psychoeducation about the function and the architecture of sleep, to assess sleep quality and disturbance and to create a case formulation. Nursing staff will be trained in specific cognitive techniques that target night time worries and the handling of hallucinations/voices. The interventions will be manualized, securing equality in treatment for all patients. A clinical psychologist with CBT training, stationed at the ward, will take part in the initial assessment and will offer support in the creating the case formulation. The standardized evaluation using symptom checklists and sleep checklists will also be conducted by the psychologist or doctor in charge. Supervision will be given in groups led by a clinical psychologist on a weekly basis as well as ad hoc troubleshooting and problem solving on a daily basis. The individual treatment will include an activity plan for each patient prepared in close collaboration with our wards occupational therapist concerning. This will involve good wake up routines and winding down-routines, light exposure to reestablish circadian rhythm and activating activities to counteract the need for daytime naps that disturbs the build-up of sleep pressure. Much of the described measures are already part our established inpatient nursing services or "treatment as usual". The focus of our project, however, will be to systemize these interventions in light of a 24 hour cycle aimed specifically to target the promotion of good sleep. Before discharge, the psychologist or doctor in charge will conduct a reevaluation using symptom checklist as well as an interview focusing on lessons learned and tool acquired by our patients struggling with chronic sleep disturbances in how to cope with these challenges after their discharge.
All patients on all three psychosis wards will receive standard evidence based treatment for psychosis and affective disorders as per today. All patients on the two wards not receiving the treatment protocol will also be offered to wear a monitoring device on order to register potential sleep disturbances. All patients who choose to wear a monitoring device, will be offered a psychoeducative session with a psychologist trained in CBT upon discharge.
Primary outcome will be the quantity and quality of sleep as measured by clinical records on sleep duration, sleep onset, number of awakenings, bed time, rise time and medication used. Secondary outcomes will be symptom load as measured by clinical records of nursing category (PK) and Brøset Violence Checklist (BVC), symptom measurements for psychosis (PANSS), for mania (YMRS) and global assessment of function (GAF). In addition daily dosage of medication such as antipsychotics, mood stabilizers, benzodiazepines and sleep inducing medication, as well as registered aggressive events will be measured. In most cases the patient is admitted involuntary and time until their legal status is changed from involuntary to voluntary will be calculated as a measurement of insight and health improvement. Finally, average number of bed days, ward level of violence and wards cost of medication for the three wards will be calculated and compared for all patients admitted during the study period.
Patients admitted to an acute psychiatric ward are very often not able to give informed consent upon admittance due to psychotic symptoms. Those who are able to give informed consent upon discharge will be asked to sign a broad consent. For those patients who consent upon discharge, data will be gathered for all patients on all three psychosis wards and compared against each other. Aggregated and anonymized data will be gathered and compared across the three wards. We have estimated that 90 (45+45) participants are required in order to meet our aims. In order to provide an answer as to whether this treatment is cost effective for the department by comparing total number of bed days, ward level of violence and wards cost of medication, we have calculated that we need a larger sample size of approximately 200 (100+100). We have implemented the broad consent at the Department of Acute Psychiatry and based on our experience, only 30-40 % of the patients choose to or are able to consent to research even when they are stable. We therefore expect that the intervention period will go on for approximately 6 months in order to achieve the number needed.
Due to the corona outbreak, the inclusion of patients for the AkuSleep study has been postponed indefinitely. The ward that was dedicated to the intervention has been transformed to a specialized unit treating psychiatric patients with either known COVID-19 or having symptoms of COVID-19. The study will start including patients when the Norwegian Health authorities have declared the outbreak to be under control and the ward is again offering standard treatment to patients with psychotic disorders.
- Conditions
- Sleep Disturbance, Psychotic Disorders
- Being tested
- Modified CBT for insomnia, Treatment as usual
- Keywords
- Sleep Disturbance, Psychotic Disorders
- Medical subject headings
- Parasomnias, Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modified CBT for insomniaBehavioural
Nurses who are working closely with the patients around the clock will perform an adjusted and modified version of CBT for sleep disturbances, in addition to standard evidence based treatment for psychosis and affective disorders as per today.
Treatment as usualBehavioural
All patients on the two other psychosis wards will receive standard evidence based treatment for psychosis and affective disorders as per today.
| Study group | Role | What they receive |
|---|---|---|
| Modified CBT for insomnia | Other | All patients admitted to one of the psychosis ward will be offered the same customized treatment focusing on sleep in addition to treatment as usual. Receives: Behavioral: Modified CBT for insomnia |
| Treatment as usual | Other | All patients admitted to the other two psychosis wards will only receive treatment as usual. Receives: Behavioral: Treatment as usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of sleep
Nursing staff report hours of sleep and number of awakening based on their observations which are recorded in the clinical record by night staff. All patients who receive treatment will be offered the opportunity to keep a sleeping diary for psycheducative purposes. The patients who are able to, will fill out the Insomnia Severity Index which is a brief instrument for assessment of sleep disturbances. In addition all patients, except those who cannot wear one for security reasons, will be offered an actigraph which provides the patient with a clear picture of their sleeping pattern. Relevant data from these actigraphs will be noted in the patients' clinical records.
Measured: 10 months
Secondary outcomes (12)
Psychotic symptoms
Current psychotic symptoms will be rated with the 6-item version of the Positive and Negative Syndrome Scale (PANSS).
Measured: 10 months
Mania symptoms
Current manic symptoms will be rated using the Young Mania Rating Scale (YMRS).
Measured: 10 months
Depressive symptoms
Depressive symptoms will be assessed with the Montgomery and Åsberg Depression Rating Scale (MADRS).
Measured: 10 months
Psychosocial functioning
Psychosocial functioning in patients will be assessed with the Global Assessment of Functioning (GAF) scale, split version.
Measured: 10 months
Brøset Violence Checklist (BVC)
BVC is a short-term violence prediction instrument assessing the six items confusion, irritability, boisterousness, verbal threats, physical threats and attacks on objects as either present of absent. The BVC is scored at every shift and at a scale ranging from 0-6 depending of the number of items present. Scores of 0 is considered low risk of imminent violent risk. A score of 1-2 predicts a moderate risk of violence and where preventive measures are advised and scores above 2 predict a high risk and preventive measures are necessary to secure safety.
Measured: 10 months
Nursing category (PK-score)
Categories 1 and 2 describe patients that might be in need of some motivational support, but are aware of their condition and their needs and have the ability to take an active part in their own treatment. Global assessment of function scores (GAF) are typically in the above 45 range.Categories 3 and 4 describe patients with a clear need of nursing assistance. GAF scores are above 35. There is a need for consecutive risk assessments. The patients in these categories have a limited understanding of their condition and their need for treatment and limited ability to take part in planning of treatment. Patients in categories 3 and 4 are typically in need of hospital treatment. Categories 5 to 7 describe patients where there is an established to imminent risk of harm to self and/or others, where impulse control is failing and where the patient's ability to self-care is declining.
Measured: 10 months
Disease severity
Number of days receiving involuntary treatment.
Measured: 10 months
Number of days of stay.
Number of days that the patient is admitted before discharge.
Measured: 10 months
Average bed days per ward.
Average number of bed days for each psychosis ward.
Measured: 10 months
Aggressive events
Number of unwanted aggressive events as registered in clinical records and in the Hospital's reporting system (Achilles).
Measured: 10 months
Medication
The current medication will be obtained through the medical records. Defined daily dosages (DDD) will calculated in accordance with the guidelines from the World Health Organization Collaborating Center for Drug Statistics Methodology (hhtp://www.whocc.no/atcdd). Total use of medication per ward.
Measured: 10 months
Patient satisfaction
Upon discharge patients will be asked to fill out the Psychiatric Inpatient Questionnaire (PIPEQ) for rating their satisfaction with the treatment.
Measured: 10 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Mar 2020
- Study start1 Sep 2020
- Primary completion30 Jun 2021 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sleep DisturbanceStudies of the same condition, open and under way.
- More trials run by Oslo University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- Oslo University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- St. Olavs Hospital
- Responsible party
- Principal investigator, Ingrid Dieset, Oslo University Hospital
- Investigators
- Ingrid Dieset, MD/PhD, Principal investigator, Oslo University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04290650
- Sponsor's protocol ID
- 50984
- Acronym
- AkuSleep
- Status last verified
- Jun 2021
- First submitted
- 24 Feb 2020
- Last updated
- 28 Jun 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jun 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The AkuSleep Study- Treating Sleep Disturbances in Patients With Psychotic Symptoms in an Acute Ward Setting Using Cognitive Behavioral Treatment Techniques
- ClinicalTrials.gov ID
- NCT04290650
- Acronym / sponsor ID
- AkuSleep / 50984
- Conditions
- Sleep Disturbance, Psychotic Disorders
- Keywords
- Sleep Disturbance, Psychotic Disorders
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 75 participants (actual)
- Lead sponsor
- Oslo University HospitalUniversity, hospital or other
- Collaborators
- St. Olavs Hospital
- Study start
- 1 Sep 2020 (actual)
- Primary completion
- 30 Jun 2021 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 2 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sleep disturbance is recognized as a major problem for patients with psychosis and is seen in nearly all patients admitted in acute crisis to a psychiatric hospital.
Cognitive behavioral treatment is recommended as first-line treatment for insomnia in national and international guidelines. This study explores effect of adapting the milieu therapy to comply with the principles of CBT for insomnia. Our aim is to rethink our day to day psychological interventions and our around the clock milieu therapy for patients with acute and severe mental illness in light of established knowledge on how sleep is obtained and maintained.
Detailed description
Sleep disturbances are highly prevalent among patients admitted to any hospital ward, but in particular in psychiatric patients where insomnia and poor sleep quality is a major clinical challenge.
Approximately 950 patients are admitted to The Acute Psychiatric Department at Oslo University each year. The majority of the patients (approximately 450) admitted for more than 48 hours have a severe psychotic disorder and after being evaluated by a psychiatrist upon admittance, they are allocated to one of three similar wards specialized in the treatment of psychosis. A majority of the patients experience sleep difficulties both in terms of insomnia and problems regulating circadian rhythm. Psychiatric wards in general offer several challenges to sleep, including limited access to natural daylight, noisy environment and frequent observations by staff during night for risk management purposes. A part from offering medication which the patient often declines, staff members possess little means as to how to cope with noise and agitation at night time due to frustrated patients unable to find rest.
In September 2019 our department started organizing the treatment for psychotic patients in three similar wards ("psychosis wards") and patients were allocated to a ward according to their date of birth. Nurses are stationed permanently at each ward, while psychiatrist and psychologists make up a "specialist pool" serving all three psychosis wards. One of the main intentions for organizing the department and treatment this way is to ensure that all patients with psychotic disorders receive the same treatment according to recommended guidelines.
The aim of our study is to rethink our day to day psychological interventions and our around the clock milieu therapy for our patients with acute and severe mental illness in light of established knowledge on how sleep is obtained and maintained. After making physical adjustments to the ward environment and training allocated nurses in modified CBT techniques, the AkuSleep intervention will start up in March 2020 and will be carried out for up to six months. All patients admitted one of the psychosis wards will be offered the same customized treatment focusing on sleep, whereas all the patients admitted to the other two psychosis wards will receive treatment as usual (TAU). Upon discharge, all patients admitted to the Department of Acute Psychiatry who are able to give informed consent are asked to give a broad consent allowing us to systemize clinical information from hospital records for research purposes.
The AkuSleep protocol is as follows:
- Identify the nature of the patient's sleeping problems and discuss suitable adjustments with the patient. These adjustments would typically be to focus on circadian rhythm, such as getting up in the morning at set times, avoiding coffee and strenuous physical and emotional activities at night time, avoiding staying in bed when sleep is not achieved and optimizing light/dark exposure. An acute ward setting such as ours is often noisy and many of our patients have restrictions due to security reasons which limit the access to natural day light. Simple physical measures will be implemented such as providing ear plugs, providing night lamps so that staff don't need to turn on lights on rounds, secure speakers so that the patients may listen to soothing music, easy blinds to secure a dark room at night and bean bags (or chairs) in every room so that the patient can get out of bed when sleep is not achieved. The use of daylight lamps will be offered for patients who due to security reasons or otherwise are denied access to natural daylight.
- Trained nurses will perform a short 20 minute daily session with the patient addressing tailored measures in accordance with the modified CBT for insomnia. Assessment of the individual patient's specific sleeping problems is vital for an effective treatment. Sleeping problems/disorders typically falls in to three categories; disturbance in the sleep/wake homeostasis, disturbance in the circadian rhythm and/or hyperarousal. Detecting the nature of the sleeping disorder, maintenance factors and individual goals for treatment will give way to a sleep-focused case formulation that will guide further strategies. The use of sleep and activity monitoring devices will be offered for those who find it useful. Information from monitoring devices will be used for the purpose psychoeducation and as basis for the sleep diary and relevant information will be registered in the clinical records. Data from monitoring devices will not be stored electronically. Intentions available for the patient and therapist are gathered from CBT for insomnia and will involve establishing a firm associations between bed and sleep through the use of stimulus control and the setting of a consistent sleep window (time spent in bed); activity scheduling to promote good wake-up routines and help build up necessary sleep pressure; targeting hyperarousal through systematic wind-down strategies, relaxation training etc. Psychotic symptoms such as hallucinations and delusions are also prone to give disturbance in the ability to either getting to or staying asleep. These symptoms will be incorporated in the specific formulation for treatment and management of the symptoms will be a part of later strategies promoting good sleep hygiene. The implemented measures will be monitored and evaluated throughout the whole period so that adjustments can be made on a daily basis and in accordance with the formulation and the patient's goals. The details of the individual treatment progress will be written in a patient owned workbook, giving all trained staff members an opportunity to step in at any time to continue the therapeutic work. The workbook will be given to the patient at their time of discharge with instructions of further use.
The teaching of the nursing staff will cover topics to enable them to give psychoeducation about the function and the architecture of sleep, to assess sleep quality and disturbance and to create a case formulation. Nursing staff will be trained in specific cognitive techniques that target night time worries and the handling of hallucinations/voices. The interventions will be manualized, securing equality in treatment for all patients. A clinical psychologist with CBT training, stationed at the ward, will take part in the initial assessment and will offer support in the creating the case formulation. The standardized evaluation using symptom checklists and sleep checklists will also be conducted by the psychologist or doctor in charge. Supervision will be given in groups led by a clinical psychologist on a weekly basis as well as ad hoc troubleshooting and problem solving on a daily basis. The individual treatment will include an activity plan for each patient prepared in close collaboration with our wards occupational therapist concerning. This will involve good wake up routines and winding down-routines, light exposure to reestablish circadian rhythm and activating activities to counteract the need for daytime naps that disturbs the build-up of sleep pressure. Much of the described measures are already part our established inpatient nursing services or "treatment as usual". The focus of our project, however, will be to systemize these interventions in light of a 24 hour cycle aimed specifically to target the promotion of good sleep. Before discharge, the psychologist or doctor in charge will conduct a reevaluation using symptom checklist as well as an interview focusing on lessons learned and tool acquired by our patients struggling with chronic sleep disturbances in how to cope with these challenges after their discharge.
All patients on all three psychosis wards will receive standard evidence based treatment for psychosis and affective disorders as per today. All patients on the two wards not receiving the treatment protocol will also be offered to wear a monitoring device on order to register potential sleep disturbances. All patients who choose to wear a monitoring device, will be offered a psychoeducative session with a psychologist trained in CBT upon discharge.
Primary outcome will be the quantity and quality of sleep as measured by clinical records on sleep duration, sleep onset, number of awakenings, bed time, rise time and medication used. Secondary outcomes will be symptom load as measured by clinical records of nursing category (PK) and Brøset Violence Checklist (BVC), symptom measurements for psychosis (PANSS), for mania (YMRS) and global assessment of function (GAF). In addition daily dosage of medication such as antipsychotics, mood stabilizers, benzodiazepines and sleep inducing medication, as well as registered aggressive events will be measured. In most cases the patient is admitted involuntary and time until their legal status is changed from involuntary to voluntary will be calculated as a measurement of insight and health improvement. Finally, average number of bed days, ward level of violence and wards cost of medication for the three wards will be calculated and compared for all patients admitted during the study period.
Patients admitted to an acute psychiatric ward are very often not able to give informed consent upon admittance due to psychotic symptoms. Those who are able to give informed consent upon discharge will be asked to sign a broad consent. For those patients who consent upon discharge, data will be gathered for all patients on all three psychosis wards and compared against each other. Aggregated and anonymized data will be gathered and compared across the three wards. We have estimated that 90 (45+45) participants are required in order to meet our aims. In order to provide an answer as to whether this treatment is cost effective for the department by comparing total number of bed days, ward level of violence and wards cost of medication, we have calculated that we need a larger sample size of approximately 200 (100+100). We have implemented the broad consent at the Department of Acute Psychiatry and based on our experience, only 30-40 % of the patients choose to or are able to consent to research even when they are stable. We therefore expect that the intervention period will go on for approximately 6 months in order to achieve the number needed.
Due to the corona outbreak, the inclusion of patients for the AkuSleep study has been postponed indefinitely. The ward that was dedicated to the intervention has been transformed to a specialized unit treating psychiatric patients with either known COVID-19 or having symptoms of COVID-19. The study will start including patients when the Norwegian Health authorities have declared the outbreak to be under control and the ward is again offering standard treatment to patients with psychotic disorders.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Modified CBT for insomnia | Other | Behavioral: Modified CBT for insomniaAll patients admitted to one of the psychosis ward will be offered the same customized treatment focusing on sleep in addition to treatment as usual. |
| Treatment as usual | Other | Behavioral: Treatment as usualAll patients admitted to the other two psychosis wards will only receive treatment as usual. |
Who may qualify
- Ages
- 18 to 95 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All patients admitted to th he Acute Psychiatric Department at Oslo University who are able to consent
Key exclusion criteria (1 listed)
- Patients not able to consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modified CBT for insomniaNurses who are working closely with the patients around the clock will perform an adjusted and modified version of CBT for sleep disturbances, in addition to standard evidence based treatment for psychosis and affective disorders as per today. | Behavioural | Modified CBT for insomnia |
| Treatment as usualAll patients on the two other psychosis wards will receive standard evidence based treatment for psychosis and affective disorders as per today. | Behavioural | Treatment as usual |
Primary outcome
Assessment of sleep
Time frame: 10 months
Nursing staff report hours of sleep and number of awakening based on their observations which are recorded in the clinical record by night staff. All patients who receive treatment will be offered the opportunity to keep a sleeping diary for psycheducative purposes. The patients who are able to, will fill out the Insomnia Severity Index which is a brief instrument for assessment of sleep disturbances. In addition all patients, except those who cannot wear one for security reasons, will be offered an actigraph which provides the patient with a clear picture of their sleeping pattern. Relevant data from these actigraphs will be noted in the patients' clinical records.
12 secondary outcomes
Psychotic symptoms
Time frame: 10 months
Mania symptoms
Time frame: 10 months
Depressive symptoms
Time frame: 10 months
Psychosocial functioning
Time frame: 10 months
Brøset Violence Checklist (BVC)
Time frame: 10 months
Nursing category (PK-score)
Time frame: 10 months
Disease severity
Time frame: 10 months
Number of days of stay.
Time frame: 10 months
Average bed days per ward.
Time frame: 10 months
Aggressive events
Time frame: 10 months
Medication
Time frame: 10 months
Patient satisfaction
Time frame: 10 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jun 2021.
- Individual participant dataSharing planned: No
Related trials for Sleep Disturbance
Recruiting
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness
Nocturia, Insomnia
Recruiting
Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
Histamine, Cowhage
RecruitingObservational study
Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)
Ondine Syndrome (Congenital Central Hypoventilation Syndrome)
Not yet recruiting
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
RecruitingObservational study
Development and Validation of a Multimodal Deep Learning Model Using Peripheral Oxygen Saturation and Ballistocardiography Signals for Predicting Apnea-Hypopnea Index in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ingrid Dieset, MD/PhD principal investigator
Oslo University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Modified CBT for insomnia and Treatment as usual in people with Sleep Disturbance and Psychotic Disorders, run by Oslo University Hospital at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of sleep (time frame: 10 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2021.